Keyes Stange & Wooten Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
4,906
-10
-0.2% -$2.33K 0.5% 20
2026
Q1
$1.2M Buy
4,916
+425
+9% +$99K 0.54% 20
2025
Q4
$929K Sell
4,491
-186
-4% -$36.8K 0.44% 23
2025
Q3
$867K Sell
4,677
-129
-3% -$22.1K 0.42% 25
2025
Q2
$734K Sell
4,806
-17
-0.4% -$2.61K 0.38% 30
2025
Q1
$800K Buy
4,823
+2,059
+74% +$322K 0.45% 28
2024
Q4
$400K Sell
2,764
-2,261
-45% -$350K 0.24% 46
2024
Q3
$814K Buy
5,025
+110
+2% +$17.5K 0.48% 26
2024
Q2
$718K Buy
4,915
+107
+2% +$15.9K 0.5% 26
2024
Q1
$761K Buy
4,808
+2,101
+78% +$334K 0.67% 23
2023
Q4
$424K Buy
+2,707
New +$415K 0.45% 38

Other funds holding JNJ

Keyes Stange & Wooten Wealth Management's JNJ Position: Q2 2026 in Review

Keyes Stange & Wooten Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.2% in Q2 2026, selling an estimated $2.33K and leaving 4,906 shares worth $1.25M. The position accounts for 0.5% of the portfolio, ranked #20.

Keyes Stange & Wooten Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Keyes Stange & Wooten Wealth Management held 4,906 shares of Johnson & Johnson worth $1.25M as of Q2 2026.
  • Keyes Stange & Wooten Wealth Management sold 10 Johnson & Johnson shares in Q2 2026, an estimated $2.33K.
  • Johnson & Johnson made up 0.5% of Keyes Stange & Wooten Wealth Management's portfolio in Q2 2026, its #20 holding.
  • Keyes Stange & Wooten Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Keyes Stange & Wooten Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.